| Derick Thomas, PA-C | |
|
2605 Kentucky Ave Ste 102, Paducah, KY 42003-3800 | |
| (270) 228-3973 | |
| (270) 359-5046 |
| Full Name | Derick Thomas |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 2605 Kentucky Ave Ste 102, Paducah, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003339920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA2242 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Paducah | Paducah, KY | Hospital |
| Jackson Purchase Medical Center | Mayfield, KY | Hospital |
| Murray-calloway County Hospital | Murray, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Institute Of Western Kentucky Pllc | 6204226061 | 29 |
| Orthopedic Institute Of Western Kentucky Spine, Llc | 1052773488 | 3 |
News Archive
An estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults. Chronically high blood pressure damages capillaries of the kidneys which in turn affects the organ's ability to filter waste and remove excess fluids from the body.
Mayo Clinic in Arizona is the first medical center in Arizona and the Southwest to provide a new technology that treats dry eye by targeting blocked eyelid glands. Blocked glands can inhibit production of oil that is necessary for healthy tears needed to lubricate the eyes.
Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
A new study published in the current issue of Psychotherapy and Psychosomatics explores the role of sexuality in the long-term outcome of anorexia nervosa and bulimia nervosa.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derick Thomas, PA-C 2605 Kentucky Ave Ste 102, Paducah, KY 42003-3800 Ph: (270) 228-3973 | Derick Thomas, PA-C 2605 Kentucky Ave Ste 102, Paducah, KY 42003-3800 Ph: (270) 228-3973 |
News Archive
An estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults. Chronically high blood pressure damages capillaries of the kidneys which in turn affects the organ's ability to filter waste and remove excess fluids from the body.
Mayo Clinic in Arizona is the first medical center in Arizona and the Southwest to provide a new technology that treats dry eye by targeting blocked eyelid glands. Blocked glands can inhibit production of oil that is necessary for healthy tears needed to lubricate the eyes.
Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
A new study published in the current issue of Psychotherapy and Psychosomatics explores the role of sexuality in the long-term outcome of anorexia nervosa and bulimia nervosa.
› Verified 9 days ago
Reagan Poe, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1903 Broadway St Ste B, Paducah, KY 42001 Phone: 270-444-8183 Fax: 270-444-8147 | |
Mrs. Thu-trang Cleo Thi King, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2501 Kentucky Ave, Paducah, KY 42003 Phone: 270-575-2180 Fax: 270-575-8479 | |
Mr. Brandon Howard Morehead, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2520 New Holt Rd, Paducah, KY 42001 Phone: 270-556-1488 | |
Mrs. Linda Mae Moran, CERT SURG 1ST ASST Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 275 Wedgewood Place, Paducah, KY 42001 Phone: 270-442-7167 Fax: 270-442-7167 | |
Derek N Nance, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1530 Lone Oak Rd, Paducah, KY 42003 Phone: 270-444-2150 Fax: 270-444-2985 | |
Melinda P Garrett, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3101 Parisa Dr., Paducah, KY 42003 Phone: 270-444-8477 Fax: 270-444-8479 |